The customer's meter and test strips were requested for investigation.The reporter's meter and one test strip were provided for investigation where they were tested using a retention control.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.4 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
|
It was alleged that a patient received a questionable test result when testing with coaguchek xs meter serial number (b)(4).When testing with the meter at 9:30 a.M.On (b)(6) 2022, the patient received a result of 1.9 inr.Within 4 hours of the meter test, the patient allegedly received a laboratory value of 2.5 inr when tested with an unknown method.It was reported that decisions were made based on the laboratory value instead of the meter value.The patient's therapeutic range is reported to be "around 2.6 inr".The patient's testing frequency is reported to be every 2 weeks.
|